lobbying_activities: 3048871

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3048871	e6676d64-1d7d-4289-96ed-72047cf137cf	Q3	DAVE KOLBE CONSULTING	401104329	PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION	2023	third_quarter	PHA	Inflation Reduction Act (IRA) - Opposing Expansion of IRA Bill's Drug Coverage. While understanding the intention to provide wider access to affordable medications, we believe this proposed expansion could have unintended negative consequences on employment with the prescription drug industry. Protecting Patients Against PBM Abuses Act (H.R. 2880) - Urging support of H.R. 2880. 2023 Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) - Oppose legislation to expand upon the recent bipartisan language in the draft to reintroduce the concept of "Reasonable Pricing" requirements.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2023-10-13T10:53:37-04:00